PPH vs. GERM
PPH (VanEck Vectors Pharmaceutical ETF) and GERM (Amplify Treatments, Testing and Advancements ETF) are both Health & Biotech Equities funds - PPH tracks the MVIS US Listed Pharmaceutical 25 Index while GERM tracks the Prime Treatments, Testing and Advancements Index. Both are passively managed. Over the past year, PPH returned 17.87% vs 0.00% for GERM. PPH charges 0.36%/yr vs 0.68%/yr for GERM.
Performance
PPH vs. GERM - Performance Comparison
Loading charts...
Returns By Period
PPH
- 1D
- 0.33%
- 1M
- -0.56%
- YTD
- -0.76%
- 6M
- 2.14%
- 1Y
- 17.87%
- 3Y*
- 12.03%
- 5Y*
- 9.22%
- 10Y*
- 7.46%
GERM
- 1D
- 0.00%
- 1M
- 0.00%
- YTD
- 0.00%
- 6M
- 0.00%
- 1Y
- 0.00%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
PPH vs. GERM - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
PPH VanEck Vectors Pharmaceutical ETF | -0.76% | 22.00% | -9.93% |
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% |
PPH vs. GERM - Sectors Allocation Comparison
Sectors
PPH
GERM
Healthcare
Industrials
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
Real Estate
-
-
Technology
-
-
Utilities
-
-
Healthcare
PPH
GERM
Industrials
PPH
GERM
-
Basic Materials
PPH
-
GERM
-
Communication Services
PPH
-
GERM
-
Consumer Cyclical
PPH
-
GERM
-
Consumer Defensive
PPH
-
GERM
-
Energy
PPH
-
GERM
-
Financial Services
PPH
-
GERM
Real Estate
PPH
-
GERM
-
Technology
PPH
-
GERM
-
Utilities
PPH
-
GERM
-
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
PPH vs. GERM — Risk / Return Rank
PPH
GERM
PPH vs. GERM - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Pharmaceutical ETF (PPH) and Amplify Treatments, Testing and Advancements ETF (GERM). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| PPH | GERM | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | — | — | |
| Sortino ratioReturn per unit of downside risk | — | — | |
| Omega ratioGain probability vs. loss probability | 1.19 | — | — |
| Calmar ratioReturn relative to maximum drawdown | 1.67 | — | — |
| Martin ratioReturn relative to average drawdown | 3.88 | — | — |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| PPH | GERM | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.04 | — | — |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.61 | — | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.44 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.30 | — | — |
Drawdowns
PPH vs. GERM - Drawdown Comparison
The maximum PPH drawdown since its inception was -51.45%, which is greater than GERM's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for PPH and GERM.
Loading charts...
Drawdown Indicators
| PPH | GERM | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -51.45% | 0.00% | -51.45% |
Max Drawdown (1Y)Largest decline over 1 year | -10.76% | 0.00% | -10.76% |
Max Drawdown (3Y)Largest decline over 3 years | -18.06% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -20.26% | — | — |
Max Drawdown (10Y)Largest decline over 10 years | -29.70% | — | — |
Current DrawdownCurrent decline from peak | -8.34% | 0.00% | -8.34% |
Average DrawdownAverage peak-to-trough decline | -17.31% | 0.00% | -17.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.61% | 0.00% | +4.61% |
Volatility
PPH vs. GERM - Volatility Comparison
VanEck Vectors Pharmaceutical ETF (PPH) has a higher volatility of 4.73% compared to Amplify Treatments, Testing and Advancements ETF (GERM) at 0.00%. This indicates that PPH's price experiences larger fluctuations and is considered to be riskier than GERM based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| PPH | GERM | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 4.73% | 0.00% | +4.73% |
Volatility (6M)Calculated over the trailing 6-month period | 11.67% | 0.00% | +11.67% |
Volatility (1Y)Calculated over the trailing 1-year period | 17.26% | 0.00% | +17.26% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 15.07% | 0.00% | +15.07% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.96% | 0.00% | +16.96% |
PPH vs. GERM - Expense Ratio Comparison
PPH has a 0.36% expense ratio, which is lower than GERM's 0.68% expense ratio.
Dividends
PPH vs. GERM - Dividend Comparison
PPH's dividend yield for the trailing twelve months is around 2.12%, while GERM has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
GERM Amplify Treatments, Testing and Advancements ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
PPH VanEck Vectors Pharmaceutical ETF | 2.12% | 1.78% | 1.98% | 2.09% | 1.55% | 1.62% | 1.66% | 1.77% | 1.97% | 1.92% | 2.43% | 1.93% |
Frequently Asked Questions
PPH has higher volatility (4.73%) compared to GERM (0.00%). In terms of maximum drawdown, PPH dropped -51.45% vs GERM's 0.00%.
On 1-year performance, PPH leads with 17.87% vs 0.00% for GERM. On fees, PPH is cheaper at 0.36% per year. On volatility, GERM has been the lower-risk option at 0.00%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, PPH has performed better with a 17.87% return vs 0.00%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
PPH is cheaper with a 0.36% expense ratio, compared with 0.68% for GERM.
PPH has the higher dividend yield at 2.12%, compared with 0.00% for GERM.
PPH tracks MVIS US Listed Pharmaceutical 25 Index, while GERM tracks Prime Treatments, Testing and Advancements Index. They also come from different issuers: VanEck and Amplify. Their fees differ too: 0.36% for PPH and 0.68% for GERM.
Find the right allocation for PPH and GERM
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer